March 03, 2020 Roche move endorses Iteos’s Tigit widget A private Belgian biotech reckons Tigit is the new PD-1, a view Roche’s progress could validate.
January 31, 2020 Roche’s next immuno-oncology combo is a big bet on Tigit Almost in stealth mode the Swiss firm moves to begin a huge pivotal programme rivalling that of the IDO and IL-2 mechanisms.
